Literature DB >> 7751590

Liver injury related to amoxycillin-clavulanic acid: interlobular bile-duct lesions and extrahepatic manifestations.

M L Hautekeete1, R Brenard, Y Horsmans, J Henrion, L Verbist, G Derue, P Druez, M Omar, M Kockx, H Hubens.   

Abstract

We report eight cases of liver injury related to amoxycillin-clavulanate. Liver biopsy performed in seven patients revealed varying degrees of injury to interlobular bile ducts in all cases. Lesions included irregularity of the nuclei, vacuolization of the cytoplasm, lymphocytic infiltration, destruction and endothelialization of the bile duct epithelium. Ductopenia was not observed. In two patients liver injury was accompanied by prominent extrahepatic manifestations (acute interstitial nephritis in one and acute lacrimal gland inflammation and sialadenitis with prolonged xerostomia in the other). We conclude that interlobular bile-duct lesions of varying severity are a common feature in liver injury related to amoxycillin-clavulanate. Side effects of the drug include acute interstitial nephritis and sialadenitis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7751590     DOI: 10.1016/0168-8278(95)80262-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  11 in total

1.  Prolonged cholestasis with ductopenia after administration of amoxicillin/clavulanic acid.

Authors:  J P Richardet; A Mallat; E S Zafrani; M Blazquez; J C Bognel; B Campillo
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

2.  Hepatotoxicity in patients with cirrhosis, an often unrecognized problem: lessons from a fatal case related to amoxicillin/clavulanic acid.

Authors:  R J Andrade; M I Lucena; M C Fernández; J L Vega; R Camargo
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

Review 3.  Important elements for the diagnosis of drug-induced liver injury.

Authors:  Vijay K Agarwal; John G McHutchison; Jay H Hoofnagle
Journal:  Clin Gastroenterol Hepatol       Date:  2010-02-17       Impact factor: 11.382

Review 4.  Drug-induced cholestasis.

Authors:  Manmeet S Padda; Mayra Sanchez; Abbasi J Akhtar; James L Boyer
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

5.  Hepatobiliary Quiz (Answers)-16 (2015).

Authors:  Sahaj Rathi; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2015-12-21

Review 6.  Antibacterial-induced hepatotoxicity. Incidence, prevention and management.

Authors:  D K George; D H Crawford
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

7.  Co-amoxiclav jaundice: clinical and histological features and HLA class II association.

Authors:  J O'Donohue; K A Oien; P Donaldson; J Underhill; M Clare; R N MacSween; P R Mills
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

8.  Mycophenolate mofetil for drug-induced vanishing bile duct syndrome.

Authors:  S-Simona Jakab; A-Brian West; Dennis-M Meighan; Robert S Brown; William-B Hale
Journal:  World J Gastroenterol       Date:  2007-12-07       Impact factor: 5.742

9.  Acute cholestatic hepatitis caused by amoxicillin/clavulanate.

Authors:  Daniel Oliveira Beraldo; Joanderson Fernandes Melo; Alexandre Vidal Bonfim; Andrei Alkmim Teixeira; Ricardo Alkmim Teixeira; André Loyola Duarte
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

Review 10.  Acute liver failure due to amoxicillin and amoxicillin/clavulanate.

Authors:  Robert J Fontana; A Obaid Shakil; Joel K Greenson; Ian Boyd; William M Lee
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.